199 related articles for article (PubMed ID: 20961696)
1. Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancer.
Ellis RJ; Kaminsky DA; Zhou EH; Fu P; Chen WD; Brelin A; Faulhaber PF; Bodner D
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):29-34. PubMed ID: 20961696
[TBL] [Abstract][Full Text] [Related]
2. Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide.
Ellis RJ; Zhou H; Kim EY; Fu P; Kaminsky DA; Sodee B; Colussi V; Vance WZ; Spirnak JP; Kim C; Resnick MI
Brachytherapy; 2007; 6(1):16-25. PubMed ID: 17284381
[TBL] [Abstract][Full Text] [Related]
3. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
[TBL] [Abstract][Full Text] [Related]
4. Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.
Hardie AD; Rieter WJ; Bradshaw ML; Gordon LL; Young MA; Keane TE
World J Urol; 2013 Dec; 31(6):1327-32. PubMed ID: 23595605
[TBL] [Abstract][Full Text] [Related]
5. Progress in SPECT/CT imaging of prostate cancer.
Seo Y; Franc BL; Hawkins RA; Wong KH; Hasegawa BH
Technol Cancer Res Treat; 2006 Aug; 5(4):329-36. PubMed ID: 16866563
[TBL] [Abstract][Full Text] [Related]
6. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging.
Wong WW; Schild SE; Vora SA; Ezzell GA; Nguyen BD; Ram PC; Roarke MC
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e423-9. PubMed ID: 21477947
[TBL] [Abstract][Full Text] [Related]
7. 111-In-capromab pendetide imaging using hybrid-γ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer.
Tsivian M; Wright T; Price M; Mouraviev V; Madden JF; Kimura M; Wong T; Polascik TJ
Urol Oncol; 2012; 30(2):150-4. PubMed ID: 20189846
[TBL] [Abstract][Full Text] [Related]
8. Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion.
Ellis RJ; Zhou H; Kaminsky DA; Fu P; Kim EY; Sodee DB; Colussi V; Spirnak JP; Whalen CC; Resnick MI
Brachytherapy; 2007; 6(2):149-56. PubMed ID: 17434109
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer.
Nagda SN; Mohideen N; Lo SS; Khan U; Dillehay G; Wagner R; Campbell S; Flanigan R
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):834-40. PubMed ID: 17293236
[TBL] [Abstract][Full Text] [Related]
10. Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD; Goodman MM
Radiology; 2011 Jun; 259(3):852-61. PubMed ID: 21493787
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.
Rieter WJ; Keane TE; Ahlman MA; Ellis CT; Spicer KM; Gordon LL
Clin Nucl Med; 2011 Oct; 36(10):872-8. PubMed ID: 21892036
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
Raj GV; Partin AW; Polascik TJ
Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
[TBL] [Abstract][Full Text] [Related]
13. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
14. Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
Koontz BF; Mouraviev V; Johnson JL; Mayes J; Chen SH; Wong TZ; Anscher MS; Sun L; Moul J; Polascik TJ
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):358-61. PubMed ID: 18164863
[TBL] [Abstract][Full Text] [Related]
15. Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy.
Kimura M; Tsivian M; Mouraviev V; Mayes JM; Price MM; Bannister MC; Madden JF; Wong TZ; Polascik TJ
Int J Urol; 2009 Dec; 16(12):971-5. PubMed ID: 19843189
[TBL] [Abstract][Full Text] [Related]
16. Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma.
Ellis RJ; Vertocnik A; Sodee B; Zhou H; Kim E; Young B; Fu P; Colussi V; Spirnak JP; Dinchman KH; Resnick MI
Brachytherapy; 2003; 2(4):215-22. PubMed ID: 15062129
[TBL] [Abstract][Full Text] [Related]
17. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.
Schettino CJ; Kramer EL; Noz ME; Taneja S; Padmanabhan P; Lepor H
AJR Am J Roentgenol; 2004 Aug; 183(2):519-24. PubMed ID: 15269050
[TBL] [Abstract][Full Text] [Related]
18. Adaptive cone-beam CT planning improves long-term biochemical disease-free survival for
Peters M; Smit Duijzentkunst DA; Westendorp H; van de Pol SMG; Kattevilder R; Schellekens A; van der Voort van Zyp JRN; Moerland MA; van Vulpen M; Hoekstra CJ
Brachytherapy; 2017; 16(2):282-290. PubMed ID: 28110899
[TBL] [Abstract][Full Text] [Related]
19. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
Rosenthal SA; Haseman MK; Polascik TJ
Tech Urol; 2001 Mar; 7(1):27-37. PubMed ID: 11272670
[TBL] [Abstract][Full Text] [Related]
20. In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT.
Seo Y; Aparici CM; Cooperberg MR; Konety BR; Hawkins RA
J Nucl Med; 2010 Jan; 51(1):31-6. PubMed ID: 20008977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
